share_log

Genprex Collaborators To Present Preclinical Data On Use Of Reqorsa And On NPRL2 Gene Therapy Utilizing Non-Viral Oncoprex Delivery System For Lung Cancers At 2024 AACR Annual Meeting

Benzinga ·  Mar 6 21:36

Reqorsa Immunogene Therapy May be a Potential Therapy for ALK-Positive Lung Cancer

REQORSA has Anti-Tumor Mechanisms that Target and Disrupt the Metabolism of Cancer Cells

NPRL2 Gene Therapy Induces Effective Anti-Tumor Immunity in Non-Small Cell Lung Cancer Humanized Mouse Model

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment